814 related articles for article (PubMed ID: 26195549)
1. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
[TBL] [Abstract][Full Text] [Related]
2. Secreted Toxoplasma gondii molecules interfere with expression of MHC-II in interferon gamma-activated macrophages.
Leroux LP; Dasanayake D; Rommereim LM; Fox BA; Bzik DJ; Jardim A; Dzierszinski FS
Int J Parasitol; 2015 Apr; 45(5):319-32. PubMed ID: 25720921
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
[TBL] [Abstract][Full Text] [Related]
4. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
[TBL] [Abstract][Full Text] [Related]
5. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
[TBL] [Abstract][Full Text] [Related]
6. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression.
Lang C; Algner M; Beinert N; Gross U; Lüder CG
Microbes Infect; 2006 Jul; 8(8):1994-2005. PubMed ID: 16824778
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.
Lüder CG; Lang C; Giraldo-Velasquez M; Algner M; Gerdes J; Gross U
J Neuroimmunol; 2003 Jan; 134(1-2):12-24. PubMed ID: 12507768
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor MS-275 augments expression of a subset of IFN-γ-regulated genes in Toxoplasma gondii-infected macrophages but does not improve parasite control.
Sumpf K; Nast R; Downie B; Salinas G; Lüder CGK
Exp Parasitol; 2017 Sep; 180():45-54. PubMed ID: 28189488
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines.
Pepper M; Dzierszinski F; Wilson E; Tait E; Fang Q; Yarovinsky F; Laufer TM; Roos D; Hunter CA
J Immunol; 2008 May; 180(9):6229-36. PubMed ID: 18424745
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii.
Lüder CG; Lang T; Beuerle B; Gross U
Clin Exp Immunol; 1998 May; 112(2):308-16. PubMed ID: 9649196
[TBL] [Abstract][Full Text] [Related]
11. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
Deckert-Schlüter M
Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
[TBL] [Abstract][Full Text] [Related]
12. Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection.
Tu L; Moriya C; Imai T; Ishida H; Tetsutani K; Duan X; Murata S; Tanaka K; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2009 Dec; 39(12):3385-94. PubMed ID: 19830724
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii glycosylphosphatidylinositols up-regulate major histocompatibility complex (MHC) molecule expression on primary murine macrophages.
Debierre-Grockiego F; Molitor N; Schwarz RT; Lüder CG
Innate Immun; 2009 Feb; 15(1):25-32. PubMed ID: 19201822
[TBL] [Abstract][Full Text] [Related]
14. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A
J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126
[TBL] [Abstract][Full Text] [Related]
15. Suppression of major histocompatibility complex class II-associated invariant chain enhances the potency of an HIV gp120 DNA vaccine.
Lu X; Wu S; Blackwell CE; Humphreys RE; von Hofe E; Xu M
Immunology; 2007 Feb; 120(2):207-16. PubMed ID: 17116173
[TBL] [Abstract][Full Text] [Related]
16. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii.
Gubbels MJ; Striepen B; Shastri N; Turkoz M; Robey EA
Infect Immun; 2005 Feb; 73(2):703-11. PubMed ID: 15664908
[TBL] [Abstract][Full Text] [Related]
17. Expression of invariant chain (CD 74) and major histocompatibility complex (MHC) class II antigens in the human fetus.
Badve S; Deshpande C; Hua Z; Lögdberg L
J Histochem Cytochem; 2002 Apr; 50(4):473-82. PubMed ID: 11897800
[TBL] [Abstract][Full Text] [Related]
18. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
19. Subcellular antigen location influences T-cell activation during acute infection with Toxoplasma gondii.
Gregg B; Dzierszinski F; Tait E; Jordan KA; Hunter CA; Roos DS
PLoS One; 2011; 6(7):e22936. PubMed ID: 21829561
[TBL] [Abstract][Full Text] [Related]
20. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
